Skip to content

Rapet RF

by Stanbio Laboratory

510(k) K974370

Rapet RF is a medical device (FDA Class II; FDA product code DHR, System, Test, Rheumatoid Factor) made by Stanbio Laboratory, cleared under FDA 510(k) K974370 on 17 Feb 1998, active as of 22 Oct 2026. One FDA recall is linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

1 closed

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK974370 Date17 Feb 1998ClearedStatusActive

Official records

From the FDA record

Received by the FDA
20 Nov 1997
FDA decision
17 Feb 1998 (Substantially Equivalent)
FDA review time
89 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K974370 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

1 recall · FDA

    • Terminated Z-1070-2018 FDA Class II initiated 13 Feb 2018

    All patient serum samples yield a weakly positive test result.

Timeline

2 dated events

  1. Cleared FDA 510(k) K974370
  2. Recall initiated FDA recalls Z-1070-2018

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
DHR
Device class
Class II
Regulation
21 CFR Part 866.5775
Advisory committee
Immunology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code DHR (System, Test, Rheumatoid Factor).

Other devices from Stanbio Laboratory

See all devices from Stanbio Laboratory →